Diabetes Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia Riyadh Military Hospital, Riyadh, Kingdom of Saudi Arabia Discipline of Medicine, University of Sydney, Sydney, NSW, Australia.
Diabetes Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia Discipline of Medicine, University of Sydney, Sydney, NSW, Australia
Diabetes Care. 2016 May;39(5):823-9. doi: 10.2337/dc15-0991. Epub 2016 Mar 22.
This study compared the prevalence of complications in 354 patients with T2DM diagnosed between 15 and 30 years of age (T2DM15-30) with that in a duration-matched cohort of 1,062 patients diagnosed between 40 and 50 years (T2DM40-50). It also examined standardized mortality ratios (SMRs) according to diabetes age of onset in 15,238 patients covering a wider age-of-onset range.
Complication status was assessed according to a standard protocol and extracted from our electronic database. Survival status was ascertained by data linkage with the Australian National Death Index. SMRs were calculated in comparison with the background Australian population and analyzed according to age of onset.
After matching for duration, despite their younger age, T2DM15-30 had more severe albuminuria (P = 0.004) and neuropathy scores (P = 0.003). T2DM15-30 were as commonly affected by metabolic syndrome factors as T2DM40-50 but less frequently treated for hypertension and dyslipidemia (P < 0.0001). An inverse relationship between age of diabetes onset and SMR was seen, which was the highest for T2DM15-30 (3.4 [95% CI 2.7-4.2]). SMR plots adjusting for duration show that for those with T2DM15-30, SMR is the highest at any chronological age, with a peak SMR of more than 6 in early midlife. In contrast, mortality for older-onset groups approximates that of the background population.
The negative effect of diabetes on morbidity and mortality is greatest for those diagnosed at a young age compared with T2DM of usual onset. These results highlight the growing imperative to direct attention toward young-onset T2DM and for effective interventions to be applied before middle age.
本研究比较了 15 至 30 岁(T2DM15-30)和 40 至 50 岁(T2DM40-50)确诊的 354 例 T2DM 患者与匹配的病程患者的并发症发生率,并根据糖尿病发病年龄,在涵盖更广泛发病年龄范围的 15238 例患者中,检查标准化死亡率比(SMR)。
并发症状态根据标准方案进行评估,并从我们的电子数据库中提取。通过与澳大利亚国家死亡指数的数据链接来确定生存状态。SMR 与背景澳大利亚人群进行比较,并根据发病年龄进行分析。
尽管年龄较小,但在匹配病程后,T2DM15-30 患者的蛋白尿(P=0.004)和神经病变评分(P=0.003)更严重。T2DM15-30 患者与 T2DM40-50 患者一样常见代谢综合征因素,但接受高血压和血脂异常治疗的频率较低(P<0.0001)。糖尿病发病年龄与 SMR 呈反比关系,T2DM15-30 的 SMR 最高(3.4[95%CI 2.7-4.2])。调整病程后 SMR 图显示,对于 T2DM15-30 患者,任何实际年龄的 SMR 均最高,在中年早期 SMR 峰值超过 6。相比之下,年龄较大的发病组的死亡率与背景人群相近。
与通常发病的 T2DM 相比,发病年龄较小的患者糖尿病对发病率和死亡率的负面影响最大。这些结果强调了将注意力转向年轻发病的 T2DM 的必要性,并迫切需要在中年之前采取有效的干预措施。